|
HY-138635-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0]
|
|
Cancer-programmed cell death
|
|
|
HY-138635-1mL
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-12 [CAS 2417370-90-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138632-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138632-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-9 [CAS 2417370-42-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P78810-10ug
|
MedChemexpress LLC
|
Protein L, Finegoldia magna (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-P78810-5ug
|
MedChemexpress LLC
|
Protein L, Finegoldia magna (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-P78810-50ug
|
MedChemexpress LLC
|
Protein L, Finegoldia magna (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-134797-10mg
|
MedChemexpress LLC
|
p-SCN-Bn-deferoxamine [CAS 1222468-90-7]
|
|
|
|
|
HY-134797-5mg
|
MedChemexpress LLC
|
p-SCN-Bn-deferoxamine [CAS 1222468-90-7]
|
|
|
|
|
HY-P9949-1mg
|
MedChemexpress LLC
|
Reslizumab [CAS 241473-69-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9949-2mg
|
MedChemexpress LLC
|
Reslizumab [CAS 241473-69-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1509-1mg
|
MedChemexpress LLC
|
Rhodopsin Epitope Tag [CAS 102099-07-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1509-10mg
|
MedChemexpress LLC
|
Rhodopsin Epitope Tag [CAS 102099-07-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1509-5mg
|
MedChemexpress LLC
|
Rhodopsin Epitope Tag [CAS 102099-07-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P9998-1mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P9998-10mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-P9998-5mg
|
MedChemexpress LLC
|
Semzuvolimab [CAS 2409099-32-5]
|
|
Cancer-programmed cell death
|
|
|
HY-D1375-10mg
|
MedChemexpress LLC
|
Sulfo-Cy5 amine [CAS 2183440-44-8]
|
|
|
|
|
HY-D1375-5mg
|
MedChemexpress LLC
|
Sulfo-Cy5 amine [CAS 2183440-44-8]
|
|
|
|
|
HY-D1389-10mg
|
MedChemexpress LLC
|
Sulfo-CY-5.5 NHS ester (tripotassium) [CAS 2419286-92-1]
|
|
|
|
|
HY-D1389-25mg
|
MedChemexpress LLC
|
Sulfo-CY-5.5 NHS ester (tripotassium) [CAS 2419286-92-1]
|
|
|
|
|
HY-D1389-5mg
|
MedChemexpress LLC
|
Sulfo-CY-5.5 NHS ester (tripotassium) [CAS 2419286-92-1]
|
|
|
|
